124 related articles for article (PubMed ID: 35347884)
1. Cytomorphologic features of thyroid nodules harboring thyroid adenoma-associated fusion: A single institutional review of 11 cases.
Roberts JW; Lubin DJ; Shi Q; Viswanathan K
Diagn Cytopathol; 2022 Jul; 50(7):327-334. PubMed ID: 35347884
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive evaluation of cytomorphologic, histologic, and molecular features of DICER1-altered thyroid lesions on FNA: A multipractice experience.
Lengyel K; Lubin DJ; Hsiao WY; Sirotnikov S; Luo G; Roberts JW; Shi Q; Magliocca K; Lewis MM; Sears DL; Ilyas G; Rogers BB; Viswanathan K
Cancer Cytopathol; 2024 Jun; 132(6):359-369. PubMed ID: 38520219
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic Characteristics of Thyroid Nodules Positive for the
Morariu EM; McCoy KL; Chiosea SI; Nikitski AV; Manroa P; Nikiforova MN; Nikiforov YE
Thyroid; 2021 Aug; 31(8):1212-1218. PubMed ID: 33487086
[No Abstract] [Full Text] [Related]
4. THADA-IGF2BP3 fusions detected in fine-needle aspiration specimens of thyroid nodules: An institutional experience.
Gubbiotti MA; Andrianus S; Baloch Z
Diagn Cytopathol; 2023 Jun; 51(6):349-355. PubMed ID: 36752652
[TBL] [Abstract][Full Text] [Related]
5. Cytomorphologic features of NTRK-rearranged thyroid carcinoma.
Viswanathan K; Chu YH; Faquin WC; Sadow PM
Cancer Cytopathol; 2020 Nov; 128(11):812-827. PubMed ID: 33074583
[TBL] [Abstract][Full Text] [Related]
6. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
Desai D; Lepe M; Baloch ZW; Mandel SJ
Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
[TBL] [Abstract][Full Text] [Related]
7. Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases.
Jitpasutham T; Andrianus S; Gubbiotti M; Nosé V; Baloch ZW; Madrigal E; Faquin WC
Cancer Cytopathol; 2024 Jun; 132(6):370-385. PubMed ID: 38558329
[TBL] [Abstract][Full Text] [Related]
8. Follicular lesion of undetermined significance in thyroid FNA revisited.
Walts AE; Mirocha J; Bose S
Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
[TBL] [Abstract][Full Text] [Related]
9. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules.
Goldstein RE; Netterville JL; Burkey B; Johnson JE
Ann Surg; 2002 May; 235(5):656-62; discussion 662-4. PubMed ID: 11981211
[TBL] [Abstract][Full Text] [Related]
10. Cytologic features of focal papillary thyroid carcinoma arising within follicular adenoma: a masked cytomorphologic analysis of 17 cases.
Ono JC; Wilbur DC; Lee H; Yang J; Krane JF; Bongiovanni M; Faquin WC
Acta Cytol; 2011; 55(6):531-8. PubMed ID: 22156462
[TBL] [Abstract][Full Text] [Related]
11. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
Kwon HJ; Kim EK; Kwak JY
Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369
[TBL] [Abstract][Full Text] [Related]
12. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
Agarwal S; Bychkov A; Jung CK; Hirokawa M; Lai CR; Hong S; Kwon HJ; Rangdaeng S; Liu Z; Su P; Kakudo K; Jain D
Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
[TBL] [Abstract][Full Text] [Related]
14. Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?
Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
Cytopathology; 2021 Jan; 32(1):37-44. PubMed ID: 32803788
[TBL] [Abstract][Full Text] [Related]
15. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.
Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW
Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499
[TBL] [Abstract][Full Text] [Related]
16. Fine-needle aspiration cytomorphology of papillary thyroid carcinoma with NTRK gene rearrangement from a case series with predominantly indeterminate cytology.
Abi-Raad R; Prasad ML; Adeniran AJ; Cai G
Cancer Cytopathol; 2020 Nov; 128(11):803-811. PubMed ID: 32931153
[TBL] [Abstract][Full Text] [Related]
17. Histologic and clinical follow-up of thyroid fine-needle aspirates in pediatric patients.
Partyka KL; Huang EC; Cramer HM; Chen S; Wu HH
Cancer Cytopathol; 2016 Jul; 124(7):467-71. PubMed ID: 26970342
[TBL] [Abstract][Full Text] [Related]
18. Has Afirma gene expression classifier testing refined the indeterminate thyroid category in cytology?
Yang SE; Sullivan PS; Zhang J; Govind R; Levin MR; Rao JY; Moatamed NA
Cancer Cytopathol; 2016 Feb; 124(2):100-9. PubMed ID: 26422098
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
20. Fine-needle aspiration of the macrofollicular and microfollicular subtypes of the follicular variant of papillary carcinoma of the thyroid.
Mesonero CE; Jugle JE; Wilbur DC; Nayar R
Cancer; 1998 Aug; 84(4):235-44. PubMed ID: 9723599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
